Concepedia
Statistics
Publications
4
Citations
178
H-Index
Active since
1992
Affiliations
Vertex Pharmaceuticals (United States)(Current)
M. A. O'Brien is an author at Vertex Pharmaceuticals (United States) specializing in dialysis, pharmacology, and medicine.
Publications per year
1992–2008
3 COLCHICINE VERSUS PEG-INTERFERON ALFA 2B LONG TERM THERAPY: RESULTS OF THE 4 YEAR COPILOT TRIAL
Nezam H. Afdhal, R Levine, R. Brown et al. · Journal of Hepatology · 2008 · 84 citations
Pharmacy, Pharmacology, Pharmacotherapy +11
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
David W. Dowdy, M. A. O'Brien, David Bishai · PubMed · 2008 · 68 citations
Public Health, Pharmacoeconomics, Preventive Medicine +17
Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis.
M. A. O'Brien, Nancy A. Mason · PubMed · 1992 · 14 citations
Medicine, Pharmacokinetics, Pharmacology +17
The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
Hood Sa, M. A. O'Brien, R. Higgins · PubMed · 2000 · 12 citations
Medicine, Hematology, Nephrology +17
1–4 of 4